Centogene N.V.

Company Snapshot

Founded: 2006
Entity Type: Public
Employees: 493
Region: Middle East
Revenue: $52.5 Millions
Revenue Year: 2023
Headquarter: Rostock, Germany
Key Geographics: North America, Europe, Middle East, Latin America, Asia-Pacific
Corporate Address: Am Strande 7 18055 Rostock Germany Tel. +49-381-80113-500 www.centogene.com

Company Overview

Centogene is a rare disease diagnostics company. It integrates multiomic technologies (phenomics, genomics, transcriptomics, epigenomics, proteomics, and metabolomics) with its proprietary Centogene Biodatabank and CentoCard-based sample logistics system to provide multidimensional analysis to guide the next generation of precision medicine. The Centogene Biodatabank is a real-world data repository for rare and neurogenerative diseases. It contains over 850,000 patient’ samples from over 120 countries, over 70% of whom are of non-European descent. CentoCard is a sample collection filter card for DNA, RNA, enzymes, and metabolic biomarker extraction.

Financial Highlights (FY 2023)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Centogene N.V. In Reports

Rare Disease Diagnostics: Technologies and Global Markets

BCC Research Report: Dive into Rare Disease Diagnostics Market report includes applications, industries, and services is given for 2023 and 2024, and then forecast through 2029.

Biobanking: Technologies and Global Markets

BCC Research Market Report for biobanking is estimated to increase from $61.1 billion in 2021 to $76.2 billion by 2026, at a compound annual growth rate of 4.5%

Global DNA Sequencing: Research, Applied and Clinical Markets

BCC Research Market Report for DNA Sequencing Industry. Global market for DNA sequencing technologies and their applications in research, applied and clinical segments.

Company's Business Segments

  • Pharmaceutical : This segment provides a variety of products and services to its pharmaceutical partners, including target and drug screening, clinical development, market access, expansion, CENTOGENE Biodatabank Licenses, and Insight Reports.
  • Diagnostics : This segment offers targeted genetic sequencing and diagnostic services to patients through its distribution partners and clients, who are typically physicians, labs, and hospitals.

Applications/End User Industries

  • Pharmaceuticals
  • Healthcare